Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Cerveau
- | Specialty :
- Radiothérapie et Chimiothérapie
- Thérapies Ciblées
Extract
Intellance 1 (M13-813) - A randomized, placebo controlled phase 2b/3 Study of ABT-414 with concurrent chemoradiation and adjuvant temozolomide in subjects with newly diagnosed glioblastoma (GBM) with epidermal growth factor receptor (EGFR) amplification (Intellance 1)